Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder
Yıl: 2022 Cilt: 47 Sayı: 3 Sayfa Aralığı: 1381 - 1383 Metin Dili: İngilizce DOI: 10.17826/cumj.1121992 İndeks Tarihi: 20-09-2022
Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder
Öz: -
Anahtar Kelime: Dikkat eksikliği hiperaktivite bozukluğu olan bir ergende modifiye salımlı metilfenidat kaynaklı Raynaud fenomeni
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editöre Mektup Erişim Türü: Erişime Açık
- 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC, American Psychiatric Association. 2013.
- 2. Golmirzaei J, Mahboobi H, Yazdanparast M, Mushtaq G, A Kamal M, Hamzei E. Psychopharmacology of attention-deficit hyperactivity disorder: effects and side effects. Curr Pharm Des. 2016;22:590-4.
- 3. Cantu C, Arauz A, Murillo Bonilla LM, López M, Barinagarrementeria F. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003;34:1667–72.
- 4. Jefferson HJ, Jayne DR Peripheral vasculopathy and nephropathy in association with phentermine. Nephrol Dial Transplant. 1999;14:1761–3.
- 5. Kokkinos J, Levine SR. Possible association of ischemic stroke with phenteramine. Stroke. 1993;24:310–3.
- 6. Karayagmurlu A, Coskun M. Successful management of methylphenidate or atomoxetine-related priapism during attention-deficit hyperactivity disorder treatment. J Clin Psychopharmacol. 2020;40:314-5.
- 7. Prete M, Fatone MC, Favoino E, Perosa F. Raynaud’s phenomenon: From molecular pathogenesis to therapy. Autoimmun Rev. 2014;13:655–67.
- 8. Yu ZJ, Parker-Kotler C, Tran K, Weller RA, Weller EB. Peripheral vasculopathy associated with psychostimulant treatment in children with attention- deficit/hyperactivity disorder. Curr Psychiatry Rep. 2010;12:111–5.
- 9. Ferahkaya H, Akça ÖF. Methylphenidate-induced raynaud’s phenomenon in two cases with attention- deficit/hyperactivity disorder. Journal of Contemporary Medicine. 2021;11:423-4.
- 10. Syed RH, Moore TL. Methylphenidate and dextroamphetamine-induced peripheral vasculopathy. J Clin Rheumatol. 2008;14:30–3.
- 11. Bayram Ö, Hergüner S. OROS-methylphenidate- induced Raynaud’s phenomenon: A dose-related side effect. J Child Adolesc Psychopharmacol. 2015;25:521–2.
- 12. Meridor K, Levy Y. Systemic sclerosis induced by CNS stimulants for ADHD: a case series and review of the literature. Autoimmun Rev. 2020;19:102439.
- 13. Khouri C, Blaise S, Carpentier P, Villier C, Cracowski JL, Roustit M. Drug-induced Raynaud’s phenomenon: beyond β-adrenoceptor blockers. Br J Clin Pharmacol. 2016;82:6–16.
- 14. Faraone SV. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neurosci Biobehav Rev. 2018;87:255–70.
- 15. Goldman W, Seltzer R, Reuman P: Association between treatment with central nervous system stimulants and Raynaud’s syndrome in children. Arthritis Rheum. 2008;58:563–6.
- 16. Monteerarat Y, Pariwatcharakul P. Methylphenidate- induced raynaud phenomenon developed after increasing methylphenidate in an adult with attention- deficit hyperactivity disorder. J Clin Psychopharmacol. 2019;39:178-9.
| APA | Gülcü Üstün N, Karayağmurlu A (2022). Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. , 1381 - 1383. 10.17826/cumj.1121992 |
| Chicago | Gülcü Üstün Nur Seda,Karayağmurlu Ali Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. (2022): 1381 - 1383. 10.17826/cumj.1121992 |
| MLA | Gülcü Üstün Nur Seda,Karayağmurlu Ali Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. , 2022, ss.1381 - 1383. 10.17826/cumj.1121992 |
| AMA | Gülcü Üstün N,Karayağmurlu A Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. . 2022; 1381 - 1383. 10.17826/cumj.1121992 |
| Vancouver | Gülcü Üstün N,Karayağmurlu A Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. . 2022; 1381 - 1383. 10.17826/cumj.1121992 |
| IEEE | Gülcü Üstün N,Karayağmurlu A "Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder." , ss.1381 - 1383, 2022. 10.17826/cumj.1121992 |
| ISNAD | Gülcü Üstün, Nur Seda - Karayağmurlu, Ali. "Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder". (2022), 1381-1383. https://doi.org/10.17826/cumj.1121992 |
| APA | Gülcü Üstün N, Karayağmurlu A (2022). Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. Cukurova Medical Journal, 47(3), 1381 - 1383. 10.17826/cumj.1121992 |
| Chicago | Gülcü Üstün Nur Seda,Karayağmurlu Ali Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. Cukurova Medical Journal 47, no.3 (2022): 1381 - 1383. 10.17826/cumj.1121992 |
| MLA | Gülcü Üstün Nur Seda,Karayağmurlu Ali Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. Cukurova Medical Journal, vol.47, no.3, 2022, ss.1381 - 1383. 10.17826/cumj.1121992 |
| AMA | Gülcü Üstün N,Karayağmurlu A Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. Cukurova Medical Journal. 2022; 47(3): 1381 - 1383. 10.17826/cumj.1121992 |
| Vancouver | Gülcü Üstün N,Karayağmurlu A Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder. Cukurova Medical Journal. 2022; 47(3): 1381 - 1383. 10.17826/cumj.1121992 |
| IEEE | Gülcü Üstün N,Karayağmurlu A "Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder." Cukurova Medical Journal, 47, ss.1381 - 1383, 2022. 10.17826/cumj.1121992 |
| ISNAD | Gülcü Üstün, Nur Seda - Karayağmurlu, Ali. "Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder". Cukurova Medical Journal 47/3 (2022), 1381-1383. https://doi.org/10.17826/cumj.1121992 |
